Scarica l'app Stockscreener
22.57
1.57%
-0.36
Dopo l'orario di chiusura:
22.57
Precedente Chiudi:
$22.93
Aprire:
$22.82
Volume 24 ore:
5.24M
Relative Volume:
0.89
Capitalizzazione di mercato:
$11.28B
Reddito:
$4.89B
Utile/perdita netta:
$-242.00M
Rapporto P/E:
-46.16
EPS:
-0.489
Flusso di cassa netto:
$315.00M
1 W Prestazione:
-1.27%
1M Prestazione:
-5.84%
6M Prestazione:
-7.65%
1 anno Prestazione:
+21.74%
Intervallo 1D:
$22.51
$23.39
Intervallo di 1 settimana:
$22.16
$23.63
Portata 52W:
$18.48
$27.98
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.57 | 11.46B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
18.81 | 60.52B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.01 | 46.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.61 | 30.11B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
489.42 | 21.34B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Canada
Elanco Animal Health (ELAN) CEO adds 126 deferred stock units - Stock Titan
Elanco (NYSE: ELAN) exec adds 65.8756 deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CFO now holds 158.6535 deferred stock units - Stock Titan
Elanco at Bank of America Global Healthcare Conference: growth, pipeline By Investing.com - Investing.com Canada
Elanco Animal Health stock holds at $14.93 on dated market data - AD HOC NEWS
Elanco Animal Health stock steadies as investors eye conference and growth targets - AD HOC NEWS
Stifel reiterates Elanco Animal Health stock rating on Befrena outlook By Investing.com - Investing.com Canada
Elanco to Participate in BofA Securities Global Healthcare Conference 2026 - PR Newswire
Elanco's innovation drives strong growth in U.S. pet health amid expanding tick and allergy seasons - Pluang
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care - PR Newswire
Elanco Animal Health (ELAN) Institutional Ownership 2026 $ELAN - MarketBeat
Is Elanco Animal Health (ELAN) Undervalued As Growth Expectations Meet A Recent Pullback? - Yahoo Finance
Elanco Animal Health Incorporated (ELAN) Latest Press Releases & Corporate News - finance.yahoo.com
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement - Yahoo Finance
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - PR Newswire
Elanco Animal Health (ELAN) CFO receives 8 deferred stock units - Stock Titan
Deferred stock award lifts Elanco Animal Health (NYSE: ELAN) exec's holdings - Stock Titan
Elanco (NYSE: ELAN) CEO adds to deferred pay with new stock grant - Stock Titan
Elanco Animal Health (ELAN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Mutts With a Mission: How Elanco and Medical Mutts Transform Lives Together - CSRwire
Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us
Elanco Director Purchases 40,000 Shares for $936,000 - Yahoo Finance
Elanco Director Purchases 40,000 Shares for $936,000 - The Motley Fool
Elanco Animal Health Inc (ELAN) Stock Price, Quote, News & History - Benzinga
Is Elanco Animal Health Inc (ELAN) Overvalued After 3.2% Rally? - GuruFocus
Pharma clinical research firm eyes former Elanco building in Greenfield - Indianapolis Business Journal
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility - marketscreener.com
Elanco Animal Health (ELAN) Stock Analysis: Unveiling a 29% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Elanco celebrates $120 million expansion of Elwood manufacturing facility - Yahoo Finance
Elanco (NYSE: ELAN) EVP now holds 9,770 deferred units - Stock Titan
Elanco (NYSE: ELAN) CFO holds 141.8242 deferred stock units - Stock Titan
Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Elanco Animal Health (NYSE:ELAN) Director Lawrence Erik Kurzius Purchases 40,000 Shares - MarketBeat
Elanco director Kurzius buys $935,920 in company stock - Investing.com
Elanco Animal Health Director Purchased Shares Worth Over $935K - TradingView
Elanco (NYSE: ELAN) director buys 40K shares, stake now 188,647 - Stock Titan
Danske Bank A S Makes New $14.35 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Fall 3.8% -- What GF Scor - GuruFocus
Stifel reiterates Buy rating on Elanco stock, $33 target By Investing.com - Investing.com Canada
245,707 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Great Lakes Advisors LLC - MarketBeat
Elanco Animal Health: New Products To Support Growth (NYSE:ELAN) - Seeking Alpha
Attention investors: You may be eligible for a $15 million Elanco Animal Health SEC fair fund payment - Claim Depot
Elanco Animal Health (NYSE:ELAN): Is More Momentum Ahead? - Kalkine Media
CNBC Final Trades: Netflix, Eli Lilly, Elanco Animal Health & MoreNetflix (NASDAQ:NFLX), Eli Lilly (NY - Benzinga
160,631 Shares in Elanco Animal Health Incorporated $ELAN Purchased by First National Bank of Omaha - MarketBeat
Shiv O'neill Purchases 3,998 Shares of Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
Elanco (NYSE: ELAN) legal chief buys 3,998 company shares - Stock Titan
FRAUD AND MANIPULATION—7th Cir.: Panel affirms dismissal of channel-stuffing allegations - VitalLaw.com
S&CO Inc. Buys Shares of 111,284 Elanco Animal Health Incorporated $ELAN - MarketBeat
7th Circ. Won't Revive Elanco Investors' Securities Fraud Suit - Law360
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):